MA06.04 Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)

Category Primary study
JournalJournal of Thoracic Oncology
Year 2022
This article has no abstract
Epistemonikos ID: d69bd8051423d918f94781679a4e6d8dbb0a227f
First added on: Feb 15, 2025